Androgen deprivation therapy: evidence-based management of side effects-Reference-Cited by-同舟云学术

Androgen deprivation therapy: evidence-based management of side effects

Published:2013-01-25 Issue:4 Volume:111 Page:543-548
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Ahmadi Hamed¹,Daneshmand Siamak¹

Affiliation:

1. USC Institute of Urology; USC/Norris Comprehensive Cancer Center; University of Southern California; Los Angeles; CA; USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11774.x/fullpdf

Reference20 articles.

1. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial;Irani;Lancet Oncol,2010

2. Management of complications of androgen deprivation therapy in the older man;Mohile;Crit Rev Oncol Hematol,2009

3. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB;Moraska;J Support Oncol,2010

4. Acupuncture for treating hot flushes in men with prostate cancer: a systematic review;Lee;Support Care Cancer,2009

5. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial;Galvao;J Clin Oncol,2009

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up;Journal of Clinical Oncology;2024-06-01

2. Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology;Frontiers in Oncology;2024-01-31

3. Examining the impact of androgen deprivation therapy, masculine self‐esteem, and psychological flexibility on distress and quality of life in men with prostate cancer;Psycho-Oncology;2024-01

4. Impact of androgen deprivation therapy on cognitive function in men with prostate cancer;BJUI Compass;2023-12-11

5. Achievable Dosimetric Constraints in Stereotactic Reirradiation for Recurrent Prostate Cancer;Practical Radiation Oncology;2023-11